Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amryt Pharma Plc ADR
(NQ:
AMYT
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 11, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amryt Pharma Plc ADR
< Previous
1
2
3
Next >
Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc
April 12, 2023
From
Amryt Pharma plc
Via
GlobeNewswire
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
April 03, 2023
From
Amryt Pharma plc
Via
GlobeNewswire
Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici
March 22, 2023
From
Amryt Pharma plc
Via
GlobeNewswire
Top 5 Health Care Stocks That Are Ticking Portfolio Bombs
March 14, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
AMYT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amryt Pharma Plc Is Fair to Shareholders
February 27, 2023
From
Halper Sadeh LLC
Via
Business Wire
Why Shares of Amryt Pharma Jumped This Week
January 12, 2023
A takeover bid by an Italian pharmaceutical and healthcare company boosted Amryt's shares.
Via
The Motley Fool
Recap: Amryt Pharma Q3 Earnings
November 03, 2022
Amryt Pharma (NASDAQ:AMYT) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
AMRYT PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amryt Pharma Plc - AMYT
February 24, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
AMRYT PUBLISHES SCHEME CIRCULAR AND ANNOUNCES THE SHAREHOLDER MEETINGS TO CONSIDER AND VOTE ON THE CHIESI ACQUISITION WILL BE HELD ON MARCH 22, 2023
February 16, 2023
From
Amryt Pharma plc
Via
GlobeNewswire
AMRYT PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amryt Pharma Plc - AMYT
January 10, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023
January 18, 2023
Via
Benzinga
S&P 500 Gains 0.6%; Albireo Pharma Shares Spike Higher
January 09, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Monday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023
January 10, 2023
Via
Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 09, 2023
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 09, 2023
Via
Benzinga
Nasdaq Surges Over 200 Points; Crude Oil Rises 2%
January 09, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Monday.
Via
Benzinga
Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday
January 09, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
US Stocks Open Higher; Dow Rises 150 Points
January 09, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Monday.
Via
Benzinga
AMYT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amryt Pharma Plc Is Fair to Shareholders
January 09, 2023
From
Halper Sadeh LLC
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 9, 2023
January 09, 2023
Via
Benzinga
Adobe To Rally 25%? Here Are 10 Other Analyst Forecasts For Monday
January 09, 2023
Via
Benzinga
Italian Privately Held Chiesi Farmaceutici To Acquire Amryt Pharma For $1.25B
January 09, 2023
Italian family-controlled global pharmaceutical company Chiesi Farmaceutici S.p.A. has agreed to acquire Amryt Pharma Plc (NASDAQ: AMYT) for an implied value of $1.25 billion in upfront consideration.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 09, 2023
Via
Benzinga
Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
January 09, 2023
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) rose 140.2% to $28.30 in pre-market trading after AstraZeneca announced plans to buy the company for up to $1.8 billion.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 09, 2023
We're starting off the week with a look at the biggest pre-market stock movers traders need to know about on Monday morning!
Via
InvestorPlace
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
January 08, 2023
From
Amryt Pharma plc
Via
GlobeNewswire
Amryt Announces Positive Top Line Results from Phase 3 Pediatric Trial of Lomitapide in HoFH
January 05, 2023
From
Amryt Pharma plc
Via
GlobeNewswire
COMP Adopts Positive Opinion on Orphan Designation for Mycapssa® for the Treatment of Carcinoid Syndrome Associated with Neuroendocrine Tumors
December 19, 2022
From
Amryt Pharma plc
Via
GlobeNewswire
European Commission approves Mycapssa® for the treatment of Acromegaly
December 05, 2022
From
Amryt Pharma plc
Via
GlobeNewswire
Amryt Announces New Patent for Mycapssa®
November 30, 2022
From
Amryt Pharma plc
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.